Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
05/04/2011 | CN102041265A Immunoassay reagent for assaying influenza A H1N1 virus antigen |
05/04/2011 | CN102041258A Preparation and application of monoclonal antibody for promyelocytic leukemia (PML) proteins |
05/04/2011 | CN102040662A Antibodies against human IL-21 receptor and uses therefor |
05/04/2011 | CN102040661A Artificial antigen and specific antibody of veterinary drug penicillin G degradation product benzylpenicilloic thiazole acid |
05/04/2011 | CN102040658A Schistosoma japonica polypeptide with immunogenicity and application thereof |
05/04/2011 | CN101555484B Recombinant human HMBOX1 expression vector, expression product thereof and antibody and application thereof |
05/04/2011 | CN101224302B Real time individuation poultry egg antibody preparation for anti Hepatitis B or C virus and preparing method and application thereof |
05/03/2011 | USRE42324 Compound for treatment of allergy and asthma |
05/03/2011 | US7935796 Monoclonal antibodies against ANGPTL3 |
05/03/2011 | US7935794 MAdCAM antibodies |
05/03/2011 | US7935793 variable heavy chain amino acid sequence of SEQ ID NO. 50 and a variable light chain amino acid sequence of SEQ ID NO. 48, designated herein as HuAIP12 |
05/03/2011 | US7935792 Antibody reacting with N-acetylglucosamine-6-O-sulfotransferase product |
05/03/2011 | US7935791 Conformation epitope of transmembrane surface protein specific immunoglobulin for use in treatment and prevention of leukemia, diabetes, arthritis, liver and cell proliferative disorders |
05/03/2011 | US7935790 Reagents for the detection of protein phosphorylation in T-cell receptor signaling pathways |
05/03/2011 | US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
05/03/2011 | US7935495 Methods of detecting early renal disease in animals |
05/03/2011 | US7935345 Monoclonal antibodies that specifically bind to and neutralize bacillus anthracis toxin, compositions, and methods of use |
05/03/2011 | US7935343 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
05/03/2011 | US7935340 Antibodies to IL-6 and use thereof |
05/03/2011 | US7935339 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
05/03/2011 | US7935338 Antibodies to treat cancer |
05/03/2011 | US7935333 Vaccine against brain protein; antiepileptic agents |
05/03/2011 | CA2469815C Methods for purifying protein |
05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
05/03/2011 | CA2350776C Novel mitogenic regulators |
05/03/2011 | CA2347066C Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
05/03/2011 | CA2328485C Humanized antibodies that recognize verotoxin ii and cell line producing same |
05/03/2011 | CA2262525C Methods of treating pulmonary diseases mediated by polyunsaturated lipid metabolites and assays for epoxide hydrolase inhibitors |
05/03/2011 | CA2246297C Use of an anti-human tnf-alpha monoclonal antibody in the manufacture of a therapeutic formulation for treating a thrombotic disorder |
05/03/2011 | CA2233207C Type cc chemokine-like protein |
05/03/2011 | CA2221893C Antibody specific for staphylococcus aureus, and use thereof |
05/03/2011 | CA2206509C Novel hedgehog-derived polypeptides |
04/29/2011 | CA2741418A1 Detection and modulation of cytochrome c acetylation |
04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
04/28/2011 | WO2011050188A1 Anti-hepsin antibodies and methods using same |
04/28/2011 | WO2011050152A2 Site-specific modification of proteins |
04/28/2011 | WO2011050071A2 Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography |
04/28/2011 | WO2011050027A2 Surface-assisted hemagglutination and hemagglutination inhibition assays |
04/28/2011 | WO2011050001A2 Anti-botulinum neurotoxin antibodies |
04/28/2011 | WO2011049956A2 Toxicity-associated genes, genetic variants, and use thereof |
04/28/2011 | WO2011049868A1 Modulators of hepatocyte growth factor activator |
04/28/2011 | WO2011049758A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
04/28/2011 | WO2011049449A1 Vhh for application in tissue repair, organ regeneration, organ replacement and tissue engineering |
04/28/2011 | WO2011049412A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
04/28/2011 | WO2011049099A1 Method for producing cancer stem cell |
04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
04/28/2011 | WO2011048598A1 Compositions and methods for treating aspergillosis |
04/28/2011 | WO2011048043A1 NON-CROSS-REACTIVE ANTI IgG ANTIBODIES |
04/28/2011 | WO2011047442A1 Modified variable domain molecules and methods for producing and using same |
04/28/2011 | WO2011038290A8 Neutralizing antibodies to hiv-1 and their use |
04/28/2011 | WO2011028811A3 Dual variable domain immunoglobulins and uses thereof |
04/28/2011 | WO2011026122A3 B7-h4 fusion proteins and methods of use thereof |
04/28/2011 | WO2011020783A3 Targeted immunoconjugates |
04/28/2011 | WO2011008974A3 Rsv f protein compositions and methods for making same |
04/28/2011 | US20110099647 Antibodies against cd38 for treatment of multiple myeloma |
04/28/2011 | US20110098450 Antibody Molecules |
04/28/2011 | US20110098449 Modulators of hepatocyte growth factor activator |
04/28/2011 | US20110098448 Anti-prion protein antibody fragment |
04/28/2011 | US20110098443 Anti-GLP-1R Antibodies and Their Uses |
04/28/2011 | US20110098441 Label target and labeling reagents comprising backbones with at least two consecutive peptide bonds |
04/28/2011 | US20110098294 Purine analogs |
04/28/2011 | US20110098225 NOVEL PEPTIDES DERIVED FROM NCAM (FGLs) |
04/28/2011 | US20110098183 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
04/28/2011 | US20110097750 Method of quantitative assessment on reproductive effort of black-lip pearl oysters using antibody specific thereto |
04/28/2011 | US20110097749 Process for producing hepcidin |
04/28/2011 | US20110097747 Monoclonal antibody binds antigen associated with human tumors |
04/28/2011 | US20110097742 Contrast agents, methods for preparing contrast agents, and methods of imaging |
04/28/2011 | US20110097735 Fluorescent pyrene compounds |
04/28/2011 | US20110097733 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite |
04/28/2011 | US20110097732 Novel biomarker for the prognosis of breast cancer |
04/28/2011 | US20110097353 Poultry viral materials and methods related thereto |
04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
04/28/2011 | US20110097342 Binding agents |
04/28/2011 | US20110097341 Treatment of Chronic Prostatitis |
04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
04/28/2011 | US20110097339 Compositions monovalent for CD28 binding and methods of use |
04/28/2011 | US20110097336 Methods for modulating mannose content of recombinant proteins |
04/28/2011 | US20110097335 Abc transporter protein expression inhibitor |
04/28/2011 | US20110097334 Novel Marker Genes for Regulatory T Cells from Human Blood |
04/28/2011 | US20110097333 Therapeutic and diagnostic agents |
04/28/2011 | US20110097332 Composition and Method of Use for HCV Immunization |
04/28/2011 | US20110097331 Antibodies that bind both il-17a and il-17f and methods of using the same |
04/28/2011 | US20110097330 Novel Gene Disruptions, Compostitions and Methods Relating Thereto |
04/28/2011 | US20110097327 Product and method for treatment of conditions associated with receptor-desensitization |
04/28/2011 | US20110097326 Anti-trkb antibodies |
04/28/2011 | US20110097323 Her2/neu-Specific Antibodies and Methods of Using Same |
04/28/2011 | US20110097319 Antibody Capable of Binding Specifically to AB-Oligomer, and Use Thereof |
04/28/2011 | US20110097314 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
04/28/2011 | US20110097276 Diagnosis of Prostate Cancer |
04/28/2011 | US20110097272 Method and Materials for Use in Diagnosing Viral Myocarditis |
04/28/2011 | US20110097270 Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
04/28/2011 | US20110097262 NOVEL ANTI-cMET ANTIBODY |
04/28/2011 | US20110097261 Amigo-2-inhibitors for treating, diagnosing or detecting cancer |
04/28/2011 | CA2779234A1 Toxicity-associated genes, genetic variants, and use thereof |
04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
04/28/2011 | CA2778481A1 Anti-hepsin antibodies and methods using same |
04/28/2011 | CA2778401A1 Integrin alpha 8-beta 1-specific monoclonal antibody |
04/28/2011 | CA2778176A1 Dual variable domain immunoglobulins and uses thereof |